Genmab — December 2021
-
Genmab/Berenberg: Utryg ved markedets tro på pipelinen - sælg
https://www.proinvestor.com/investornyt/742996/genmab-berenberg-utryg-ved-markedets-tro-pa-pipelinen-saelg -
Aktier/tendens: Grøn dag i sigte med Genmab og Ørsted i søgelyset https://www.proinvestor.com/investornyt/743003/aktier-tendens-gron-dag-i-sigte-med-genmab-og-orsted-i-sogelyset
-
Tisotumab Vedotin in Cervical Cancer: Current Status and Future Perspectives https://touchoncology.com/gynaecological-oncology/journal-articles/tisotumab-vedotin-in-cervical-cancer-current-status-and-future-perspectives/
-
Det for useriøst at have salgsanbefaling på dette kursniveau baseret nogle luftige vurderinger af pipelinens fremtidige salgspotentiale på den l
ange bane, når man samtidigt anerkender blockbusterpontialet på den mellemlange. -
på nogle
-
Jeg læser det ikke som de siger 2 BB. Men 2 andre stoffer med potentiale som dara. Altså at det er DET de mener den nuværende mcap bygger på
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind